Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Xutao Ge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, Macrophages, Acute Lung Injury, Protein Serine-Threonine Kinases. Die Arbeit nennt 106 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province, Zhejiang University.
Abstract (Originalsprache)
INTRODUCTION: Acute lung injury (ALI) is characterized by dysregulated macrophage-epithelial interactions, leading to barrier disruption and hyperinflammation. Broad-spectrum anti-inflammatory therapies are vital for managing ALI induced by diverse pathogens, yet effective interventions remain limited. OBJECTIVES: The study aimed to identify novel therapeutic natural products for ALI and elucidate their mechanisms of action, using a zebrafish-based drug screening platform followed by multi-scale validation. METHODS: An ALI-like zebrafish model was established by morpholino knockdown, followed by high-content screening of a natural compound library. In vitro, a macrophage-epithelium crosstalk model was used to assess the effect of the positive hit on barrier function. Mechanistic studies employed immunoprecipitation-mass spectrometry, co-IP and protein-protein docking. In vivo validation included zebrafish swim bladder (functional analog of mammalian lungs) injury model and three murine ALI models (LPS-, spike protein-, and live coronavirus-induced). Pathological damages were evaluated via H&E staining. QPCR, ELISA, western blot, IHC and IF were used to quantify molecular alterations. RESULTS: By knocking down the ptpn6 gene, an ALI-like zebrafish model with disrupted swim bladder formation was established. High-content screening of a natural compound library combined with structure-activity optimization identified herbacetin (HBT), a polyhydroxylated flavone, as the most potent ant-inflammatory candidate. HBT restored macrophage-induced lung epithelial barrier dysfunction in vitro by selectively inhibiting macrophage activation rather than directly affecting epithelial cells. Mechanistically, HBT-mediated SGK1 inhibition suppresses STAT1 phosphorylation and downstream inflammatory responses in lung barrier protection. HBT consistently preserved pulmonary barrier function in all the multi-scale models. CONCLUSION: Collectively, our findings not only highlight HBT's therapeutic potential for ALI but also identify the SGK1-STAT1 signaling as a novel target for macrophage-driven inflammatory diseases, offering a promising strategy for ALI intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100029, China.
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; State Key Laboratory of Chinese Medicine Modernization, College of Pharmaceutical Sciences, Zhejiang…
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province
- Zhejiang University
Zitieren
APA
Ge, X., Yu, S., Wu, S., Zhang, S., Zhao, R., & Zhao, L. (2025). Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157489
Vancouver
Ge X, Yu S, Wu S, Zhang S, Zhao R, Zhao L. Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157489
BibTeX
@article{Ge2025,
author = {Ge, Xutao and Yu, Sijia and Wu, Shang and Zhang, Shujing and Zhao, Ronghua and Zhao, Lu},
title = {Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157489}
}
EUVIMED